KWANG LEE: Open Payments
NPI 1295893394 · AMITYVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 52 payments from 7 companies in 2025. Trend: 2023 $1,837 · 2024 $1,419 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $446 |
| Lundbeck LLC | 12 | $269 |
| ABBVIE INC. | 12 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $126 |
| Neurocrine BioSciences, Inc. | 3 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
Products named: LYBALVI, REXULTI, VRAYLAR, CAPLYTA, ARISTADA, INGREZZA, COBENFY.
Industry payments across NY — which companies pay providers there.
